Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 22, 2025, Zevra Therapeutics (ZVRA) has a market cap of $0.41 billion USD. According to our data, Zevra Therapeutics is ranked No.6204 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 22, 2025 | $0.41 B |
-7.51%
|
| Dec 31, 2024 | $0.45 B |
27.33%
|
| Dec 29, 2023 | $0.35 B |
42.70%
|
| Dec 30, 2022 | $0.24 B |
-47.30%
|
| Dec 31, 2021 | $0.46 B |
-22.23%
|
| Dec 31, 2020 | $0.60 B |
84.70%
|
| Dec 31, 2019 | $0.32 B |
-78.71%
|
| Dec 31, 2018 | $1.52 B |
-56.05%
|
| Dec 29, 2017 | $3.46 B |
37.29%
|
| Dec 30, 2016 | $2.52 B |
-85.15%
|
| Dec 31, 2015 | $16.96 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Jazz Pharmaceuticals
JAZZ
|
$6.43 B |
0.153 B
|
Ireland
|
 Amarin Corporation
AMRN
|
$0.22 B |
0.000 M
|
Ireland
|
 Ironwood Pharmaceuticals
IRWD
|
$0.12 B |
3.601 M
|
USA
|
 Supernus Pharmaceuticals
SUPN
|
$1.75 B |
26.711 M
|
USA
|
 Collegium Pharmaceutical
COLL
|
$0.87 B |
3.211 M
|
USA
|
 Pacira Biosciences
PCRX
|
$1.18 B |
-0.000 M
|
USA
|
 Assertio Therapeutics
ASRT
|
$57.88 M |
1.508 M
|
USA
|
 Eli Lilly
LLY
|
$763.05 B |
19.931 B
|
USA
|
 Pfizer
PFE
|
$128.36 B |
0.580 B
|
USA
|
 Johnson & Johnson
JNJ
|
$381.49 B |
1.331 B
|
USA
|
 Merck
MRK
|
$199.10 B |
0.383 B
|
USA
|
 AbbVie
ABBV
|
$312.53 B |
5.113 B
|
USA
|
| Market Cap | = | ZVRA Stock Price | * | ZVRA Shares Outstanding |
| = | $7.31 | * | 54.12 M | |
| = | $0.41 B |